MX356006B - Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos. - Google Patents

Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos.

Info

Publication number
MX356006B
MX356006B MX2013012160A MX2013012160A MX356006B MX 356006 B MX356006 B MX 356006B MX 2013012160 A MX2013012160 A MX 2013012160A MX 2013012160 A MX2013012160 A MX 2013012160A MX 356006 B MX356006 B MX 356006B
Authority
MX
Mexico
Prior art keywords
lithocholic acid
antimicrobial peptide
elicitor
molecule
antimicrobial
Prior art date
Application number
MX2013012160A
Other languages
English (en)
Other versions
MX2013012160A (es
Inventor
Carlos Mateos Diaz Juan
Gonzalez Avila Marisela
Prado Montes De Oca Ernesto
Alberto Grajales Hernandez Daniel
Original Assignee
Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C filed Critical Centro De Investig Y Asistencia En Tecnologia Y Diseno Del Estado De Jalisco A C
Priority to MX2013012160A priority Critical patent/MX356006B/es
Priority to PCT/MX2014/000161 priority patent/WO2015057047A1/es
Publication of MX2013012160A publication Critical patent/MX2013012160A/es
Publication of MX356006B publication Critical patent/MX356006B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención refiere un método para sintetizar enzimáticamente el litocoil oleato y purificarlo de manera eficiente. El litocoil oleato es una molécula que sirve como elicitor de péptidos antimicrobianos, el cual presenta actividad antimicrobiana indirecta e inmunomoduladora al inducir la expresión o sobrexpresión de péptidos antimicrobianos e interferón tipo II (interferón-?). El litocoil es un derivado del ácido litocólico esterificado con ácido oleico en la posición alfa 3-hidroxi. Es un líquido oleoso amarillento a temperatura ambiente con un peso molecular de 641 gr/mol y fórmula química C42H72O4. Esta molécula se puede utilizar sola o en combinación con ácido ascórbico y/o glucosa, los cuales se demuestra en esta invención que son elicitores de péptidos antimicrobianos, para el tratamiento de enfermedades infecciosas y crónico-degenerativas en el humano.
MX2013012160A 2013-10-18 2013-10-18 Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos. MX356006B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013012160A MX356006B (es) 2013-10-18 2013-10-18 Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos.
PCT/MX2014/000161 WO2015057047A1 (es) 2013-10-18 2014-10-13 Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013012160A MX356006B (es) 2013-10-18 2013-10-18 Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos.

Publications (2)

Publication Number Publication Date
MX2013012160A MX2013012160A (es) 2015-04-17
MX356006B true MX356006B (es) 2018-04-24

Family

ID=52828413

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013012160A MX356006B (es) 2013-10-18 2013-10-18 Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos.

Country Status (2)

Country Link
MX (1) MX356006B (es)
WO (1) WO2015057047A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE375359T1 (de) * 1998-08-12 2007-10-15 Genaera Corp Aminosterolderivate und ihre verwendungen
EP2040713B1 (en) * 2006-06-27 2014-06-18 Intercept Pharmaceuticals Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
WO2008149563A1 (ja) * 2007-06-04 2008-12-11 Nihon University 作用選択的ビタミンｄ受容体作用剤

Also Published As

Publication number Publication date
WO2015057047A9 (es) 2015-07-02
MX2013012160A (es) 2015-04-17
WO2015057047A1 (es) 2015-04-23

Similar Documents

Publication Publication Date Title
CY1121395T1 (el) Τετραϋδροπυριδοπυραζινες-διαμορφωτες toy gpr6
AU2016204322A1 (en) N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
WO2015027259A3 (de) Polypeptid zur hydrolytischen spaltung von zearalenon und/oder zearalenon-derivaten, isoliertes polynukleotid davon sowie einen zusatzstoff enthaltendes polypeptid, verwendung desselben sowie verfahren
IN2015DN00827A (es)
PH12014502537A1 (en) Therapeutic uses of fibroblast growth factor 21 proteins
CO7141403A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
PH12015501116A1 (en) New indanyloxydihydrobenzofuranylacetic acids
MX2014015287A (es) Derivado del ester del acido heteroarilcarboxilico.
GEP20186885B (en) Novel compounds
MX350211B (es) Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico.
MX2011008899A (es) Nuevas orto-aminoamidas para el tratamiento del cancer.
EA201491155A1 (ru) Новые мутантные про-нрф и их применение для получения бета-нрф
NZ703217A (en) Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
EA201390639A1 (ru) Производные 2-пиперазин-1-ил-4н-1,3-бензотиазин-4-она и их применение для лечения инфекций у млекопитающих
JO3611B1 (ar) سايكلو بنتا (سي (بيرول 4,3 ثاني هيدرو 1 hمستبدله [8,1] نافثيريدينونات مضادة للجراثيم
UA107592C2 (uk) Композиція для боротьби з захворюваннями рослин і її застосування
WO2015021423A3 (en) Purification of chimeric fviii molecules
MX359084B (es) Péptidos antimicrobianos.
WO2012019086A3 (en) Inhibition of lar phosphatase to enhance therapeutic angiogenesis
CO7141402A2 (es) Procesos para producir ciertos 2 (piridin 3 il)tiazoles
NZ603261A (en) Anticancer steroidal lactones unsaturated in position 7 (8)
BRPI1006076B8 (pt) composições farmacêuticas
WO2015073307A3 (en) Fc CONTAINING POLYPEPTIDES HAVING INCREASED BINDING TO HUMAN DC-SIGN
MX356006B (es) Proceso para obtener una molécula que sirve como elicitor de péptidos antimicrobianos.

Legal Events

Date Code Title Description
FG Grant or registration